product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Stathmin Antibody
catalog :
3352
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section
more info or order :
Cell Signaling Technology product webpage
citations: 17
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; human; 1:50; fig 1a
Nooij L, Dreef E, Smit V, van Poelgeest M, Bosse T. Stathmin is a highly sensitive and specific biomarker for vulvar high-grade squamous intraepithelial lesions. J Clin Pathol. 2016;69:1070-1075 pubmed publisher
  • western blot; human; fig 4
Adam M, Matt S, Christian S, Hess Stumpp H, Haegebarth A, Hofmann T, et al. SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status. Cell Cycle. 2015;14:3734-47 pubmed publisher
  • western blot; mouse
Menon M, Sawada A, Chaturvedi A, Mishra P, Schuster Gossler K, Galla M, et al. Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis. PLoS Genet. 2014;10:e1004558 pubmed publisher
Tachibana H, Sho R, Takeda Y, Zhang X, Yoshida Y, Narimatsu H, et al. Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target. PLoS ONE. 2016;11:e0159693 pubmed publisher
Ong C, Chong P, McArt D, Chan J, Tan H, Kumar A, et al. The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers. Oncotarget. 2015;6:12763-73 pubmed
Hassan M, Watari H, Mitamura T, Mohamed Z, El Khamisy S, Ohba Y, et al. P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane. Oncoscience. 2015;2:294-308 pubmed
Berg A, Hoivik E, Mjøs S, Holst F, Werner H, Tangen I, et al. Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. Oncotarget. 2015;6:1327-39 pubmed
Werner H, Trovik J, Halle M, Wik E, Akslen L, Birkeland E, et al. Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer. PLoS ONE. 2014;9:e90141 pubmed publisher
Yan L, Xing Z, Guo Z, Fang Z, Jiao W, Guo X, et al. Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy. PLoS ONE. 2013;8:e55790 pubmed publisher
Brastianos P, Horowitz P, Santagata S, Jones R, McKenna A, Getz G, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013;45:285-9 pubmed publisher
Liu F, Sun Y, Xu Y, Liu F, Wang L, Zhao X. Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma. Oncol Rep. 2013;29:419-24 pubmed publisher
Kang W, Tong J, Chan A, Lung R, Chau S, Wong Q, et al. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. PLoS ONE. 2012;7:e33919 pubmed publisher
Wan X, Zhao Y, Fan X, Cai H, Zhang Y, Chen M, et al. Molecular prognostic prediction for locally advanced nasopharyngeal carcinoma by support vector machine integrated approach. PLoS ONE. 2012;7:e31989 pubmed publisher
Li F, Glinskii O, Zhou J, Wilson L, Barnes S, Anthony D, et al. Identification and analysis of signaling networks potentially involved in breast carcinoma metastasis to the brain. PLoS ONE. 2011;6:e21977 pubmed publisher
Wagner W, Ajuh P, Lower J, Wessler S. Quantitative phosphoproteomic analysis of prion-infected neuronal cells. Cell Commun Signal. 2010;8:28 pubmed publisher
Salvesen H, Carter S, Mannelqvist M, Dutt A, Getz G, Stefansson I, et al. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci U S A. 2009;106:4834-9 pubmed publisher
Verma N, Dourlat J, Davies A, Long A, Liu W, Garbay C, et al. STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. J Biol Chem. 2009;284:12349-62 pubmed publisher
product information
SKU :
3352S
Product-Name :
Stathmin Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
Cytoskeletal Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
19
Host :
Rabbit
Target :
Stathmin
Primary-Protein :
STMN1
Alt-Names :
C1orf215,FLJ32206,LAP18,Lag,Leukemia-associated phosphoprotein p18,MGC138869,MGC138870,Metablastin,OP18,Oncoprotein 18,PR22,Phosphoprotein p19,Prosolin,Protein Pr22,SMN,STMN1,Stathmin,phosphoprotein 19,pp17,pp19,stathmin 1,stathmin 1/oncoprotein 18,transmembrane protein C1orf215
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.